Silencing in action: how cells 'repress' genomic remnants of ancient viruses
It is crucial for organisms to be able to control which genes are expressed in which cells and when. Naturally occurrin…
It is crucial for organisms to be able to control which genes are expressed in which cells and when. Naturally occurrin…
OpCT-001 is the first iPSC-derived investigational cell therapy to be clinically tested for treating primary photorecept…
An entire production batch often depends on a negative sterility result (no growth) and if this batch fails, it can lead…
Lonza delivered sales of CHF 3.1 billion, growing 1.8%1 CER CHF 893 million CORE EBITDA resulted in a margin of 29.2% Ro…
Employment grows by 14% to 58,000 employees in the Bavarian biopharma sector Slight increase in the numbers of biop…
The Bavarian biotechnology company ibidi GmbH is celebrating the delivery of its 1000th Pump System. With it, ibidi has…
- REGENERATE-PD, which is now enrolling, will study AB-1005, an adeno-associated virus 2 (AAV2) glial cell line-deriv…
At ACHEMA 2024, the world's leading trade show for the process industries, 2,842 exhibitors from 56 nations showed 106,0…
Freight handling times are reduced by up to two-thirds Direct apron access and physical monitoring of shipments provide…
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s Softer performance in Q1 2024, normali…